p38 activation occurs mainly in microglia in the P301S Tauopathy mouse model

Juan R Perea1,2, Esther García1, Laura Vallés-Saiz1

  • 1Centro de Biología Molecular "Severo Ochoa", Universidad Autónoma de Madrid (UAM-CSIC) (Campus de Cantoblanco), 1 Nicolás Cabrera st, 28049, Madrid, Spain.

Scientific Reports
|February 9, 2022
PubMed

Insights

In tauopathies, p38 MAPK activation increases with age, primarily in microglia. Rod microglia, an activated form, show decreased p38 activation, suggesting a neuroprotective role in tau pathology.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Tauopathies involve hyperphosphorylated tau accumulation and neuroinflammation via microglia activation.
  • p38 MAPK pathway is implicated in neuroinflammation and tau phosphorylation, with expression in glia and neurons.

Purpose of the Study:

  • To investigate the role and localization of p38 MAPK activation in a P301S tauopathy mouse model.
  • To explore the phenotype of microglia, specifically rod microglia, in the context of aging and tau pathology.

Main Methods:

  • Utilized the P301S Tauopathy mouse model.
  • Analyzed p38 MAPK activation levels in microglia and neurons during aging.
  • Characterized microglial morphology, identifying rod microglia.

Main Results:

  • p38 MAPK activation increased with aging in the hippocampus, predominantly in microglia, not neurons.
  • Rod microglia, an activated microglial subtype, were observed in the model.
  • p38 MAPK activation was found to be decreased in this rod microglia subpopulation.

Conclusions:

  • Aging exacerbates p38 MAPK activation in hippocampal microglia in this tauopathy model.
  • Rod microglia may represent a neuroprotective phenotype, as they exhibit reduced p38 MAPK activation despite the overall increase in neuroinflammation.

Related Concept Videos